AlloMap Heart Molecular Expression Testing

AlloMap Heart Molecular Expression Testing is an FDA 510(k)-cleared medical device (K221640) manufactured by Caredx, Inc.. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 12, 2023. Regulation: 8.